Experience With Extended Infusion of Piperacillin–Tazobactam at a Teaching Hospital

Canadian Journal of Hospital Pharmacy - Canada
doi 10.4212/cjhp.v63i3.925
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Canadian Society of Hospital Pharmacists (CSHP)

Related search

Piperacillin/Tazobactam as Cause of Acute Generalized Exanthematous Pustulosis

Case Reports in Dermatological Medicine
2019English

Activity of CP 99,219 Compared With Those of Ciprofloxacin, Grepafloxacin, Metronidazole, Cefoxitin, Piperacillin, and Piperacillin-Tazobactam Against 489 Anaerobes.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1994English

Effect of Subinhibitory Concentration of Piperacillin/Tazobactam on Pseudomonas Aeruginosa

Journal of Medical Microbiology
MedicineMicrobiology
2004English

Pharmacokinetics and Pharmacodynamics of Two Multiple-Dose Piperacillin-Tazobactam Regimens.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1997English

Incidence and Risk Factors of Hypokalemia in Tazobactam/Piperacillin-Administered Patients

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2019English

Extensive Gene Amplification as a Mechanism for Piperacillin-Tazobactam Resistance in Escherichia Coli

mBio
VirologyMicrobiology
2018English

Point-Counterpoint: Piperacillin-Tazobactam Should Be Used to Treat Infections With ESBL-positive Organisms

Journal of Clinical Microbiology
Microbiology
2017English

Study of Optimal Administration Method of Tazobactam / Piperacillin Using Monte Carllo Simulation

Yamaguchi Medical Journal
2017English

Development of Acute Kidney Injury With Concomitant Use of Vancomycin and Piperacillin-Tazobactam. A Review of Recent Literature

American Journal of Hospital Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy